Skip to main content

Morning Bell 13 January

Jessica Amir
January 13, 2021

The ASX200 is eyeing a fall of 0.1% at the open. The expected pull back comes as Aussie scientists are calling for the AstraZeneca vaccine rollout to be paused given it’s only 62% effective. The Aussie Government pre-bought 54 million doses of the AstraZeneca vaccine, however Scientists say they prefer the Pfizer and Moderna vaccines as they are 95% effective.

Broad market sentiment remains high with the economy expected to recover this year, as a vaccine is said to be available in Australia as early as February.

What to watch today:

  • Oil gained 1.7% overnight rising to a new 11-month high of US$53.17.
  • Lithium stocks as the lithium price is clawing out of a 2-year bear market.

Local trading ideas:

  • Citi increased Afterpay’s (ASX:APT) price target to $115 but maintained the stock as a hold, noting app downloads somewhat slowed in December.
  • UBS reiterated CSL (ASX:CSL) as a buy with a $346 target. 21 blood-plasma collection centres have opened since July last year and UBS thinks CSL is on track to reach its FY21 target opening 20-30 centres as vaccine rollouts continue.
  • Super Retail Group (ASX:SUL) was upgraded to a buy from a hold by UBS.
  • ARB Corp (ASX:ARB), Race Oncology (ASX:RAC) and Think Childcare (ASX:TNK) are giving off strong bullish charting signals according to Trading Central.

Morning Bell 24 January

Paulina Peters
January 24, 2022

Weekly Wrap 21 January

Sophia Mavridis
January 21, 2022

Morning Bell 20 January

Paulina Peters
January 20, 2022

Morning Bell 19 January

Sophia Mavridis
January 19, 2022

Morning Bell 18 January

Paulina Peters
January 18, 2022

Morning Bell 17 January

Sophia Mavridis
January 17, 2022

Weekly Wrap 14 January

Sophia Mavridis
January 14, 2022

Morning Bell 13 January

Paulina Peters
January 13, 2022

Morning Bell 12 January

Sophia Mavridis
January 12, 2022

Morning Bell 11 January

Paulina Peters
January 11, 2022

Morning Bell 10 January

Sophia Mavridis
January 10, 2022

Thank you & see you in 2022

Sophia Mavridis
December 21, 2021